DKK402.40
0.27% today
Copenhagen, Apr 02, 04:59 pm CET
ISIN
DK0060336014
Symbol
NSIS B
Industry

Novonesis Stock price

DKK402.40
-36.30 8.27% 1M
-71.20 15.03% 6M
-5.30 1.30% YTD
+7.30 1.85% 1Y
-54.80 11.99% 3Y
+87.40 27.75% 5Y
+79.30 24.54% 10Y
Copenhagen, Closing price Wed, Apr 02 2025
-1.10 0.27%
ISIN
DK0060336014
Symbol
NSIS B
Industry

Key metrics

Market capitalization DKK188.09b
Enterprise Value DKK199.37b
P/E (TTM) P/E ratio 82.09
EV/FCF (TTM) EV/FCF 39.21
EV/Sales (TTM) EV/Sales 6.97
P/S ratio (TTM) P/S ratio 6.58
P/B ratio (TTM) P/B ratio 2.26
Dividend yield 1.54%
Last dividend (FY23) DKK6.20
Revenue (TTM) Revenue DKK28.59b
EBIT (operating result TTM) EBIT DKK4.74b
Free Cash Flow (TTM) Free Cash Flow DKK5.08b
Cash position DKK1.16b
EPS (TTM) EPS DKK4.92
P/E forward 35.49
P/S forward 5.91
EV/Sales forward 6.27
Show more

Is Novonesis a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Novonesis Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Novonesis forecast:

13x Buy
68%
4x Hold
21%
2x Sell
11%

Analyst Opinions

19 Analysts have issued a Novonesis forecast:

Buy
68%
Hold
21%
Sell
11%

Financial data from Novonesis

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
28,593 28,593
60% 60%
100%
- Direct Costs 15,062 15,062
86% 86%
53%
13,531 13,531
38% 38%
47%
- Selling and Administrative Expenses 1,651 1,651
15% 15%
6%
- Research and Development Expense 3,082 3,082
53% 53%
11%
8,798 8,798
51% 51%
31%
- Depreciation and Amortization 4,058 4,058
192% 192%
14%
EBIT (Operating Income) EBIT 4,739 4,739
7% 7%
17%
Net Profit 2,281 2,281
25% 25%
8%

In millions DKK.

Don't miss a Thing! We will send you all news about Novonesis directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.

Head office Denmark
CEO Ester Baiget
Employees 10,582
Website www.novonesis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today